Editor in Chief Dr KK Aggarwal, Padma Shri Awardee Dated:21 March,2020
WHO message to youth on coronavirus: "You are not invincible"
With more than 210,000 cases reported worldwide and a death toll of 9,000, each day brings a "new and tragic milestone", WHO Director-General Tedros Adhanom Ghebreyesus said.
By Stephanie Nebehay
CMAAO IMA HCFI COVID Myths Busters 20th March 2020
Ten seconds self-check for corona
Incorrect, a recent coronavirus "simple self-check test" has been going viral over social media is completely inaccurate as per medical experts.
COVID MEDtalks around the globe 20 March
For circulation in public interest
Signs of Spiritual Awakening
●More experiences of telepathy
●More experiences of reverse telepathy
●More spontaneous fulfillment of desires
●Increased tendency to let things happen rather than make them happen. Work done with the least effort....read more
Health Sutras By Dr K K Aggarwal
Welcome the girl child.
Healthcare News Monitor
moneycontrol- Viswanath Pilla
Indian drug major Cipla has come forward to work with Hyderabad-based Indian Institute of Chemical Technology (IICT) to develop three broadspectrum antiviral drugs - Favipiravir, Remidesivir and Bolaxavir - against novel coronavirus (COVID-19). As part of the announcement, IICT, which is part of the publicly funded Council of Scientific and Industrial Research (CSIR) will develop active pharma ingredients (APIs) of the three antiviral drugs. Cipla will take care of testing, regulatory approvals and subsequent mass production. The plan is to get the pilot batch ready in the next 6-10 weeks. IICT may receive royalties through this collaboration. It isn't Cipla alone; another small Indian drug maker Lasa SuperGenerics is taking the help of Indian Chemical Technology (ICT), Mumbai to develop Favipiravir. In this case too, the arrangement is similar. The public-funded ICT will develop the drug and Lasa will fund the bio-equivalence study, regulatory approval and commercial launch. These drugs, which were facing obscurity, are showing some promise against COVID-19, making drug companies interested.
Chloroquine, a 70-year old treatment for malaria, is being touted as a potential treatment for the deadly coronavirus these days. As per reports, a research professor in France has reported successful results from chloroquine for coronavirus, with early tests suggesting it can stop the virus from being contagious in just six days. US President Donald Trump also asserted on Thusday that the Food and Drug Administration (US FDA) had just approved the decades-old malaria drug to treat patients infected by the coronavirus. What exactly is chloroquine? Chloroquine is used for indications such as lupus, malaria and arthritis. It appears to be able to block viruses from binding to human cells and getting inside them to replicate. It also stimulates the immune system. Why Indian companies are in focus? According to reports, Indian companies are in focus on account of chloroquine. IPCA Labs’ Active Pharmaceutical Ingredient (API) for chloroquine is approved by the US Food and Drug Administration. Around 12 companies have USFDA approval to manufacture the drug in the US. Indian companies whose final drug formulation is approved by USFDA includes Cadila, IPCA, Lupin and Laurus Labs. A few companies that sell the drug in India are Cadila, IPCA and Torrent. On chloroquine drug, Pankaj Patel of Zydus Cadila - I said, “We have been watching this very carefully and we have geared up ourselves to produce more quantity. We are very confident that if need be, we would be able to ramp up production further to make sure that supply would be available for the people who need that drug."
The world has witnessed two World Wars — wars amongst the nation-states. Post 9/11, there has been a global war against terrorism. However, in recent history the world has not witnessed anything like the present, when the entire world is required to fight a war against a virus called Covid-19. As things stand today, the prevailing situation could turn into anything between ‘a wakeup call’ to a ‘dooms day scenario’. Pandemics are not new for human civilisation and in the last hundred years, the world had witnessed few pandemics. Mostly, they are known to have originated from avian influenza viruses. Influenza is caused by a virus (there are four types: A, B, C and D). Covid-19, the coronavirus is not an influenza virus. Some known viruses from this family include SARS-CoV and MERS-CoV. In the past, during the Spanish Flu (1918-1919) around 40 to 50 million people died. While Russian Flu (1889-1890), Asian Flu (1957-58) and Hong Kong Flu (1968-70) had around more than one million deaths during every epidemic. While during the Second World War (1939-1945) had around 40 to 50 million deaths happened and the First World War (1914-1918) had more than 20 million people losing their lives. A broad comparison indicates that a major pandemic can kill the almost same number of people as that of any Great War and that too in a very limited time span.
Hindustan Times- Anonna Dutt
India’s priority must be to prevent the spread of Covid-19 through social distancing and then lockdowns till science expands our toolkits, says Dr Anurag Agarwal, director of the Institute of Genomics and Integrative Biology. He is a pulmonologist and known for his research on lung diseases. Dr Agarwal says that more testing will tell us more, but the strategy to combat the disease will remain the same. He speaks to Hindustan Times on the coronavirus outbreak. Q: India has submitted two gene sequences, what have we learnt from it? Dr Agarwal: When you look at the two sequences that have been submitted by the NIV (National Institute of Virology in Pune) to the global database, you can see on the tree that the sequences are different from everywhere else. So we do not know what it will do. Also, there is not one single strain in India; people who have come back have flown through a bunch of places. If you are coming back from Italy, it doesn’t mean you have picked up the infection there, there are transit points and so many people at the airports. But, the most important thing to my mind it that so far for every case we have been able to trace the reason for that person to be infected. Till that continues, we are not looking at a background community transmission. The 11 other strains are currently being sequenced, and nobody wants to hoard on to these. Whenever they feel comfortable, when they have gone through all the scientific checks, they will release it.